Anticancer Antibody Triggers 'Outside-In' Signal, Guiding Drug Entry into Cancer Cells

Health News

Anticancer Antibody Triggers 'Outside-In' Signal, Guiding Drug Entry into Cancer Cells
Anticancer DrugP-CadherinAntibody
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 64 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 46%
  • Publisher: 71%

A new study reveals a groundbreaking mechanism by which an anticancer antibody, CQY684, utilizes a conformational change in the P-cadherin protein to trigger an 'outside-in' signaling pathway. This unique process effectively guides the antibody and its attached drug payload into cancer cells, offering a promising avenue for targeted cancer therapy.

A new study published in Nature Communications on January 29th reveals a novel signaling mechanism that could revolutionize drug delivery to cancer cells. The research, conducted by graduate students Bin Xie and Shipeng Xu, along with Professor Sanjeevi Sivasankar at the University of California, Davis, focuses on the interaction of an anticancer drug with P-cadherin, a protein often overexpressed in malignant cancers.

P-cadherin, embedded in the cell membrane, has attracted attention as a potential target for drug development due to its abundance on the surface of cancer cells. Monoclonal antibodies targeting P-cadherin can be used to deliver drugs directly to these cells. However, the precise mechanism by which these antibodies attach to P-cadherin and subsequently enter the cancer cell remained unclear.Through a series of experiments, the researchers discovered that binding of the anti-cancer antibody CQY684 to P-cadherin triggers a conformational change, locking it into a stable, cross-shaped dimer known as the X-dimer. This stable X-dimer form initiates a chemical signal that causes the surrounding cell membrane to be pinched off, effectively engulfing the antibody-P-cadherin complex within the cell as a tiny vesicle. The entire complex is then transported to a cellular structure called the lysosome for degradation. This finding reveals a previously unknown 'outside-in' signaling pathway, shedding light on how cells regulate adhesion. The research team believes that understanding the binding targets for antibodies against cadherin could pave the way for designing more effective drugs that exploit this pathway to specifically target and destroy cancer cells

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Anticancer Drug P-Cadherin Antibody Cancer Therapy Signaling Pathway

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

GenScript's Anti-Idiotype Antibody Solutions for Antibody-Drug ResearchGenScript's Anti-Idiotype Antibody Solutions for Antibody-Drug ResearchGenScript partners with researchers to develop highly sensitive and specific polyclonal and monoclonal anti-idiotype antibodies for diverse downstream applications. These antibodies, used to assess the pharmacokinetics and pharmacodynamics of antibody drugs, are also valuable reference standards for immunogenicity, anti-drug antibody studies, and neutralizing antibody measurements.
Read more »

Broadly Neutralizing Antibody Protects Monkeys Against Severe H5N1 Avian FluBroadly Neutralizing Antibody Protects Monkeys Against Severe H5N1 Avian FluUniversity of Pittsburgh and NIH researchers report that a prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu. The broadly neutralizing antibody, which recognizes a stable region of the bird flu virus, is less prone to losing efficacy than antibodies targeting more mutation-prone structures. This feature ensures lasting protection against virus variants and could be useful in controlling infection outbreaks and containing a bird flu pandemic.
Read more »

Heinz Cream of Tomato Soup Triggers Brain Responses Like a Hug, Study ProvesHeinz Cream of Tomato Soup Triggers Brain Responses Like a Hug, Study ProvesA recent study conducted by Heinz in collaboration with neuroscientists has revealed that its iconic Cream of Tomato soup triggers brain responses comparable to receiving a hug. The study, which used advanced neuroscience technology to monitor participants' brain activity, found that both the taste of the soup and the experience of a hug activated similar areas of the brain associated with pleasure and comfort.
Read more »

New discovery in HIV vaccine response reveals surprising antibody behaviorNew discovery in HIV vaccine response reveals surprising antibody behaviorMany vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection.
Read more »

Single heat stroke exposure triggers long-term health risks and metabolic vulnerabilitiesSingle heat stroke exposure triggers long-term health risks and metabolic vulnerabilitiesThe study links exertional heat stroke to chronic disorders, revealing impacts on body mass regulation and heart health, especially in high-fat diet scenarios.
Read more »

Insect Bite Triggers Life-Changing Decision for Husband Facing DiabetesInsect Bite Triggers Life-Changing Decision for Husband Facing DiabetesAn unexpected cellulitis diagnosis following an insect bite leads a man to make drastic changes to his lifestyle and dietary habits after his doctor reveals he has Type 2 diabetes.
Read more »



Render Time: 2025-02-15 07:00:33